Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Merck Discussing Another Drugmaker Buyout -- Buy Or Sell?

Merck & Co., Inc. (MRK) reported solid first-quarter results beating analysts’ estimates for sales and earnings. In addition, given that the company is in talks to acquire another biotech firm to boost its cancer-drug portfolio, would it be wise to buy the stock now? Let’s discuss.

StockNews.com

Dow Up Over 650 Points; Health Care, Biotechs The Winners This Week

The Nasdaq is on pace for a 6.4% gain for the week, while the S&P 500 is up 5.7%.

Investors Business Daily

Seagen Surges As Merck Takeover Deal Reportedly Accelerating

Merck is reportedly nearing a takeover of cancer biotech Seagen, according to a report Friday that prodded SGEN stock higher.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Jumps In Broad Rally; Zendesk Spikes On Buyout, China Stocks Keep Rising

Futures rose, with crude oil and Treasury yields also up. Zendesk soared on a buyout. Li Auto, Alibaba led China stocks higher.

Investors Business Daily

Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ

Merck & Co Inc (NYSE:MRK) is pushing forward with a potential deal for Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported, citing people familiar with the matter. The Journal mentioned that the deal could be one of the largest takeovers of the year. The Wall Street Journal reported last week that Merck was in talks to…

Benzinga

Dow Jones Regains Upside As Nasdaq Leads; These Biotechs Near Buy Points

The Dow Jones reversed higher as several health care and biotech stocks outperformed.

Investors Business Daily

Stock Market Gains As Powell Continues Testimony; Health Care Stocks Outperform

The stock market gained as low jobless claims numbers pointed to a tight job market in spite of ongoing recession fears.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Fades Gains Into Close After Powell's Recession Warning

Indexes were on track to close higher Wednesday but slipped back into the negative near the end of the session.

Investors Business Daily

Recap of Tuesday's Biotech Catalysts - End of the Day Summary

Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) Ionis shares are trading low 4 percent at $35.10 in the after-hours session

Benzinga

SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal - What Investors Need To Know

SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN).

Benzinga

Merck To Start Pivotal Trial For Next-Gen Pneumococcal Vaccine Next Month

Merck & Co Inc (NYSE:MRK) presented results from the Phase 1/2 study, evaluating V116 in pneumococcal vaccine-naïve adults 18-49 years of age (Phase 1) and 50 years of age and older (Phase 2). Data were shared at the International Symposium on Pneumococci and Pneumococcal Diseases. V116 targets serotypes that account for 85% of…

Benzinga

Stock Market Closes Higher, But Dow Jones Inches Down; Exxon And Chevron Lead Oil Stocks Lower

The stock market gained but the Dow Jones inched lower on the eve of three-day weekend. Oil stocks tumble.

Investors Business Daily

Stock Market Ending Week With Gains But Energy Stocks Continue To Slide

Crude oil futures have fallen nearly 7% today, to $109 per barrel.

Investors Business Daily

Embattled Biotech Seagen Rockets On Rumors Merck Could Buy It

Merck is reportedly eyeing a takeover of embattled biotech Seagen, according to multiple reports that sent SGEN stock flying Friday.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Merck Shows Takeover Interest In Seagen: WSJ

Merck & Co Inc (NYSE:MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported citing people familiar with the matter. If the deal happens, it would be significant, given Seagen's market value of roughly $28 billion. According to the report, some people said other unnamed suitors are also eying Seagen, a…

Investors Business Daily

Dow Jones Rises After Key Inflation Report; Fed Meeting Set To Kick Off

The Dow Jones Industrial Average rose Tuesday after another key inflation report. The Fed's two-day meeting will also kick off.

Investors Business Daily

Dow Jones Futures: What To Do After Monday's Stock Market Plunge; Fed Meeting, Key Inflation Report Next

Dow Jones futures were higher following Monday's stock market plunge. Another pivotal inflation report is due out Tuesday.

Investors Business Daily

Dow Jones Dives, Treasury Yields Surge To New Highs; Bitcoin Crashes Below $24,000

The Dow Jones Industrial Average dived over 600 points Monday, as Treasury yields surged to new highs. Bitcoin crashed below $24,000.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Dives On Hot Inflation Report; DocuSign Plunges 23% On Earnings

The Dow Jones Industrial Average dived Friday on a hot inflation report in the wake of Thursday's stock market sell-off. DocuSign plunged on earnings.

Investors Business Daily

Dow Jones Falls As Jobless Claims Jump; Tesla Rallies On China Sales

The Dow Jones Industrial Average fell Thursday after unemployment data. Tesla stock raced higher on news that May sales in China rebounded.

Investors Business Daily

Dow Jones Falls As Treasury Yields Climb; Tesla Races Higher On Battery Deal

The Dow Jones Industrial Average fell Wednesday, as Treasury yields jumped. Top stocks to buy and watch include cosmetics leader Ulta Beauty.

Benzinga

Merck, Ridgeback Announce New Molnupiravir Data From Late-Stage COVID-19 Study

Merck & Co Inc (NYSE:MRK) and Ridgeback Biotherapeutics announced that the Annals of Internal Medicine had published additional data from the Phase 3 MOVe-OUT trial of Lagevrio (molnupiravir) in non-hospitalized COVID-19 patients at high risk for progressing to severe disease. A lower proportion of molnupiravir-treated participants in the modified intent-to-treat population had an acute care…

Investors Business Daily

Dow Jones Slides As Target Dives On Profit Warning; Tesla Skids

The Dow Jones Industrial Average sold off Tuesday, as Target dived after warning profits would drop in the current quarter.

Investors Business Daily

Dow Jones Futures: Treasury Yields Jump; 7 Top Stocks To Buy And Watch Now

Dow Jones futures were lower after Monday's stock market action. The 10-year Treasury yield jumped back above 3%.

Investors Business Daily

Dow Jones Rallies As Apple Jumps Ahead Of WWDC 2022; Twitter Dives On Elon Musk Filing

The Dow Jones Industrial Average rallied 200 points Monday, as Apple jumped ahead of the company's WWDC 2022 event, while Twitter stock dived.

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.